A randomized, double-blind, placebo-controlled, multicenter, binational, phase II trial of immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy.

Kasper, S., Moehler, M., Hegewisch-Becker, S., Overkamp, F., Bechstein, W.O., Kullmann, F., Lang, H., Schoen, M., Smith-Machnow, V., Seehofer, D., Voehringer, M., Geissler, M., Greil, R., Heike, M., Heinemann, V., Lordick, F., Galle, P.R., Schimanski, C.C., 2014.

J Clin Oncol 32:5s(suppl; abstr TPS3658). doi: 10.1200/jco.2014.32.15_suppl.tps3658

Studie: LICC; Indikation: Kolorektalkarzinom; Jahr: 2014; Veranstaltung: GI (ASCO); Journal: Journal of Clinical Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com